At a March 27 public meeting, FDA gathered industry input on the scope of dietary supplement ingredients, production technologies, and regulatory considerations.
At a March 27 public meeting, FDA gathered industry input on the scope of dietary supplement ingredients, production technologies, and regulatory considerations.
Fill out the form below, and we will be in touch shortly.